National Survey on Hypertension in Cardiologic Private Practice - Full Text View

National Survey on Hypertension in Cardiologic Private Practice (Prophyl C)

This study has been completed.

Sponsored by:	AstraZeneca
Information provided by:	AstraZeneca
ClinicalTrials.gov Identifier:	NCT00695175

Purpose

To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in private cardiology consultation by holding account of type of exercise of the cardiologist (private exclusive or mixed hospital and private).

Condition
Hypertension

MedlinePlus related topics: High Blood Pressure

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Profile of Hypertensive Patients Seen in Private Cardiology Consultation

Further study details as provided by AstraZeneca:

Primary Outcome Measures:

Demographic, clinical and health care characteristics [ Time Frame: Once ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	1800
Study Start Date:	February 2008
Estimated Study Completion Date:	August 2008

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

First three consecutive patients with hypertension seen by Cardiologists

Criteria

Inclusion Criteria:

male or female > or = 18 years old
Known hypertension
agree to take part in this study

Exclusion Criteria:

none

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00695175

Show 436 Study Locations

Sponsors and Collaborators

AstraZeneca

Investigators

Study Director:

Alain Castaigne, Medical Director

AstraZeneca

More Information

Responsible Party:	AstraZeneca Pharmaceuticals ( Alain Castaigne, Medical Director )
Study ID Numbers:	NIS-CFR-DUM-2007/6
Study First Received:	June 9, 2008
Last Updated:	October 16, 2008
ClinicalTrials.gov Identifier:	NCT00695175
Health Authority:	France: French Data Protection Authority

Keywords provided by AstraZeneca:

Hypertension
Private cardiology consultation
Patients with hypertension

Study placed in the following topic categories:

Vascular Diseases
Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009